Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

First Report of Hereditary Lysozyme Amyloidosis in a South Asian Family.

Iqbal M, Jani P, Ahmed S, Sher T.

Case Rep Hematol. 2019 Feb 10;2019:5092496. doi: 10.1155/2019/5092496. eCollection 2019.

2.

A Phase I Study to Assess the Safety and Pharmacokinetics of Single-agent Lorvotuzumab Mertansine (IMGN901) in Patients with Relapsed and/or Refractory CD-56-positive Multiple Myeloma.

Ailawadhi S, Kelly KR, Vescio RA, Jagannath S, Wolf J, Gharibo M, Sher T, Bojanini L, Kirby M, Chanan-Khan A.

Clin Lymphoma Myeloma Leuk. 2019 Jan;19(1):29-34. doi: 10.1016/j.clml.2018.08.018. Epub 2018 Sep 5.

PMID:
30340993
3.

Stem cell transplantation for immunoglobulin light chain amyloidosis.

Sher T, Gertz MA.

Curr Probl Cancer. 2017 Mar - Apr;41(2):129-137. doi: 10.1016/j.currproblcancer.2017.03.001. Epub 2017 Mar 16. Review.

PMID:
28457657
4.

First report of safety and efficacy of daratumumab in 2 cases of advanced immunoglobulin light chain amyloidosis.

Sher T, Fenton B, Akhtar A, Gertz MA.

Blood. 2016 Oct 13;128(15):1987-1989. Epub 2016 Aug 19. No abstract available.

5.

Evolution of Hematopoietic Cell Transplantation for Immunoglobulin Light Chain Amyloidosis.

Sher T, Dispenzieri A, Gertz MA.

Biol Blood Marrow Transplant. 2016 May;22(5):796-801. doi: 10.1016/j.bbmt.2015.10.010. Epub 2015 Oct 22. Review.

6.

Pathophysiology and treatment of cardiac amyloidosis.

Gertz MA, Dispenzieri A, Sher T.

Nat Rev Cardiol. 2015 Feb;12(2):91-102. doi: 10.1038/nrcardio.2014.165. Epub 2014 Oct 14. Review.

PMID:
25311231
7.

Recent advances in the diagnosis and management of cardiac amyloidosis.

Sher T, Gertz MA.

Future Cardiol. 2014 Jan;10(1):131-46. doi: 10.2217/fca.13.85. Review.

PMID:
24344669
8.

Treatment of primary systemic amyloidosis (AL): role of intensive and standard therapy.

Sher T, Hayman SR, Gertz MA.

Clin Adv Hematol Oncol. 2012 Oct;10(10):644-51. Erratum in: Clin Adv Hematol Oncol. 2012 Nov;10(11):766.

PMID:
23187770

Supplemental Content

Loading ...
Support Center